Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extensive Stage Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04675697
What this trial is testing

Anlotinib Plus Platinum-etoposide in First-line of Extensive-stage Small-cell Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Xiangya Hospital of Central South University 36
Large-scale testing (Phase 3)Study completedNCT00003917
What this trial is testing

Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Case Comprehensive Cancer Center 4
Not applicableStudy completedNCT00303901
What this trial is testing

Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery

Who this might be right for
Lung CancerMetastatic Cancer
Barbara Ann Karmanos Cancer Institute 40
Large-scale testing (Phase 3)Active Not RecruitingNCT07005128
What this trial is testing

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

Who this might be right for
Small-cell Lung CancerExtensive Stage Small-cell Lung Cancer
Amgen 350
Testing effectiveness (Phase 2)Looking for participantsNCT06769126
What this trial is testing

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaLung Small Cell Carcinoma, A SubtypeLung Small Cell Carcinoma, I Subtype+2 more
SWOG Cancer Research Network 900
Early research (Phase 1)Looking for participantsNCT07037758
What this trial is testing

Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Amgen 380
Not applicableStudy completedNCT00974610
What this trial is testing

Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.

Who this might be right for
Breast CancerColorectal CancerLung Cancer+2 more
Cancer Trials Ireland 803
Large-scale testing (Phase 3)UnknownNCT03100955
What this trial is testing

Standard Treatment +/- Apatinib in Extensive Stage Small Cell Lung Cancer

Who this might be right for
Progression Free Survival
Qingdao University 120
Testing effectiveness (Phase 2)Ended earlyNCT02748889
What this trial is testing

Carboplatin Plus Etoposide With or Without MPDL3280A in Untreated Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer ( SCLC )
Giuseppe Giaccone 1
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Ended earlyNCT04422210
What this trial is testing

A Study Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Venetoclax In Combination With Atezolizumab, Carboplatin, And Etoposide In Participants With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC).

Who this might be right for
Small Cell Lung Cancer
Hoffmann-La Roche 2
Early research (Phase 1)Study completedNCT00036790
What this trial is testing

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more
University of Wisconsin, Madison
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07501169
What this trial is testing

Sacituzumab Tirumotecan in Combination With Anlotinib in Previously Treated Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Who this might be right for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Sichuan University 33
Early research (Phase 1)Active Not RecruitingNCT05361395
What this trial is testing

First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Amgen 184
Not applicableUnknownNCT02675088
What this trial is testing

Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer

Who this might be right for
Carcinoma, Small CellLung Neoplasms
Chinese Academy of Medical Sciences 186
Testing effectiveness (Phase 2)Study completedNCT02312622
What this trial is testing

Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer

Who this might be right for
Stage IV Non-small Cell Lung Cancer (NSCLC)Recurrent Non-small Cell Lung Cancer (NSCLC)Extensive-stage Small Cell Lung Cancer (SCLC)+3 more
Joel Neal 27
Testing effectiveness (Phase 2)Looking for participantsNCT07203053
What this trial is testing

A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2

Who this might be right for
Extensive Stage Lung Small Cell Cancer
ETOP IBCSG Partners Foundation 48
Testing effectiveness (Phase 2)Study completedNCT00695292
What this trial is testing

Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
SCRI Development Innovations, LLC 37
Testing effectiveness (Phase 2)UnknownNCT04659785
What this trial is testing

Fluzoparib Combined With Apatinib as Second-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer（FA-ES-SCLC）

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Tianjin Medical University Second Hospital 53
Testing effectiveness (Phase 2)Ended earlyNCT01803269
What this trial is testing

Topotecan Hydrochloride or Cyclodextrin-Based Polymer-Camptothecin CRLX101 in Treating Patients With Recurrent Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer
University of Chicago 29
Next Page